相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyclic and Linear Peptides Containing Alternate WW and RR Residues as Molecular Cargo Delivery Tools
Lois Kim et al.
MOLECULAR PHARMACEUTICS (2023)
Combination of Amphiphilic Cyclic Peptide [R4W4] and Levofloxacin against Multidrug-Resistant Bacteria
Muhammad Imran Sajid et al.
ANTIBIOTICS-BASEL (2022)
Isolation of Mycobacterium avium and other nontuberculous mycobacteria in chickens and captive birds in peninsular Malaysia
Abdul Sattar et al.
BMC VETERINARY RESEARCH (2021)
Patients with non-tuberculous mycobacteria in respiratory samples: a 5-year epidemiological study
Cristina Matesanz Lopez et al.
REVISTA ESPANOLA DE QUIMIOTERAPIA (2021)
Genetic Involvement of Mycobacterium avium Complex in the Regulation and Manipulation of Innate Immune Functions of Host Cells
Min-Kyoung Shin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients
Shafaa Munjal et al.
CLINICS AND PRACTICE (2021)
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
Charles L. Daley et al.
CLINICAL INFECTIOUS DISEASES (2020)
Cyclic Peptide [R4W4] in Improving the Ability of First-Line Antibiotics to InhibitMycobacterium tuberculosisInsidein vitroHuman Granulomas
Joshua Hernandez et al.
FRONTIERS IN IMMUNOLOGY (2020)
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens:Mycobacterium aviumandMycobacterium abscessus
Kimberly To et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management
Charles L. Daley et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields
Yuchen Huan et al.
FRONTIERS IN MICROBIOLOGY (2020)
Identification of Mycobacterium avium subsp. paratuberculosis (MAP) in Sheep Milk, a Zoonotic Problem
Sepideh Hosseiniporgham et al.
MICROORGANISMS (2020)
Azithromycin: The First Broad-spectrum Therapeutic
Anton Firth et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases
Surendra K. Sharma et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
Lassomycin and lariatin lasso peptides as suitable antibiotics for combating mycobacterial infections: current state of biosynthesis and perspectives for production
Shaozhou Zhu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis
Ahmed Aliyu Abulfathi et al.
CLINICAL PHARMACOKINETICS (2019)
Mycobacterium avium Infection in a C3HeB/FeJ Mouse Model
Deepshikha Verma et al.
FRONTIERS IN MICROBIOLOGY (2019)
Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia
M. Buziashvili et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2019)
Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis
Adrian Schmid et al.
SCIENTIFIC REPORTS (2019)
Optimization of In Vitro Mycobacterium avium and Mycobacterium intracellulare Growth Assays for Therapeutic Development
Lauren Auster et al.
MICROORGANISMS (2019)
Treatment of Mycobacterium avium Complex Pulmonary Disease
Yong-Soo Kwon et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2019)
Toxic Activation of an AAA plus Protease by the Antibacterial Drug Cyclomarin A
Michael Maurer et al.
CELL CHEMICAL BIOLOGY (2019)
In Vitro MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease
Byoung Soo Kwon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents
Neda Riahifard et al.
MOLECULES (2018)
Host Variability in NTM Disease: Implications for Research Needs
Colin Swenson et al.
FRONTIERS IN MICROBIOLOGY (2018)
Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease
Jotam G. Pasipanodya et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Synthesis and Evaluation of Antimicrobial Activity of [R4W4K]-Levofloxacin and [R4W4K]-Levofloxacin-Q Conjugates
Neda Riahifard et al.
MOLECULES (2017)
Improvement of the productivity of ecumicin, a novel anti-tuberculosis agent, from new Nonomuraea sp MJM5123
Ying-Yu Jin et al.
JOURNAL OF ANTIBIOTICS (2016)
Mycobacterium avium tumoral infection mimicking a lung adenocarcinoma: A potential diagnostic pitfall
A. A. Fiogbe et al.
REVUE DE PNEUMOLOGIE CLINIQUE (2016)
Comparative evaluation of in vitro human macrophage models for mycobacterial infection study
E. Mendoza-Coronel et al.
PATHOGENS AND DISEASE (2016)
Intermittent Antibiotic Therapy for Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
Byeong-Ho Jeong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active against Mycobacterium tuberculosis In Vivo
Wei Gao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Differential Mycobacterium bovis BCG Vaccine-Derived Efficacy in C3Heb/FeJ and C3H/HeOuJ Mice Exposed to a Clinical Strain of Mycobacterium tuberculosis
Marcela Henao-Tamayo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
Richard J. Wallace et al.
CHEST (2014)
Macrophage-pathogen interactions in infectious diseases: new therapeutic insights from the zebrafish host model
Vincenzo Torraca et al.
DISEASE MODELS & MECHANISMS (2014)
The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review
S. K. Brode et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Antibacterial Activities of Amphiphilic Cyclic Cell-Penetrating Peptides against Multidrug-Resistant Pathogens
Donghoon Oh et al.
MOLECULAR PHARMACEUTICS (2014)
Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massillense Infection and Inducible Resistance
Go-Eun Choi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Cyclic Peptides as Therapeutic Agents and Biochemical Tools
Sang Hoon Joo
BIOMOLECULES & THERAPEUTICS (2012)
Estimation of Mycobacterium avium subsp paratuberculosis Growth Parameters: Strain Characterization and Comparison of Methods
Natalia Elguezabal et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Mycobacterium avium uses apoptotic macrophages as tools for spreading
Julie Early et al.
MICROBIAL PATHOGENESIS (2011)
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study
Kate Buchacz et al.
AIDS (2010)
Cationic Amphiphiles, a New Generation of Antimicrobials Inspired by the Natural Antimicrobial Peptide Scaffold
Brandon Findlay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Mycobacterium avium complex infection in HIV/AIDS patients
Marcelo Corti et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease
DE Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Mycobacterium's arrest of phagosome maturation in macrophages requires Rab5 activity and accessibility to iron
VA Kelley et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Mycobacterium avium and Mycobacterium intracellulare infection in mammals
MF Thorel et al.
REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES (2001)
分享论文
